Promising Response to Lenalidomide-Combination Therapy in a Discordant Lymphoma Consisting of EBV-Positive Diffuse Large B-Cell Lymphoma and Angioimmunoblastic T-Cell Lymphoma: A Case Report
Pan Hu,1,* Yu Ben,1,* Juan Liu,1 Weicheng Zheng,1 Xiyue Yan,1 Yaping Zhang,2 Wenyu Shi1,2 1Department of Oncology, Affiliated Hospital of Nantong University, Nantong, Jiangsu, 226001, People’s Republic of China; 2Department of Hematology, Affiliated Hospital of Nantong University, Nantong,...
Main Authors: | Hu P, Ben Y, Liu J, Zheng W, Yan X, Zhang Y, Shi W |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-04-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/promising-response-to-lenalidomide-combination-therapy-in-a-discordant-peer-reviewed-article-OTT |
Similar Items
-
Angioimmunoblastic T-Cell Lymphoma: A Diagnostic Challenge
by: Jorge Ocampo-Garza, et al.
Published: (2014-12-01) -
Angioimmunoblastic T-cell lymphoma presenting with an acute serologic Epstein-Barr virus profile
by: Timothy Beer, et al.
Published: (2015-06-01) -
Epstein–Barr virus positive diffuse large B‐cell lymphoma transformed into angioimmunoblastic T‐cell lymphoma after treatment
by: Chaoyu Wang, et al.
Published: (2021-05-01) -
EBV status has prognostic implication among young patients with angioimmunoblastic T‐cell lymphoma
by: Ahmed E. Eladl, et al.
Published: (2020-01-01) -
Secondary cutaneous Epstein-Barr virus-associated diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma: a case report and review of literature
by: Yang Qing-Xu, et al.
Published: (2012-01-01)